Walgreens Expanding Drive-Thru Testing To 15 New Locations in Seven States
April 07 2020 - 8:00AM
Business Wire
New Abbott ID NOW COVID-19 test to provide
rapid results to patients visiting Walgreens sites
Furthering its commitment to provide greater access to COVID-19
testing and community resources, Walgreens is working to expand
drive-thru testing to 15 new sites in seven states, the company
announced today. The states included are Arizona, Florida,
Illinois, Kentucky, Louisiana, Tennessee and Texas. The expansion
is a next step building on Walgreens’ collaboration with the
Administration, federal health agencies, and state and local
authorities.
The new testing sites will utilize Abbott’s new ID NOW COVID-19
test, which delivers positive results in as little as five minutes
and negative results within 13 minutes.
The 15 locations are being finalized in collaboration with the
U.S. Department of Health and Human Services (HHS), and are planned
for select hot spot markets with escalating rates of COVID-19
cases. Walgreens plans to be able to test up to 3,000 people per
day across these additional sites, which are expected to be
activated beginning later this week.
“Walgreens remains committed to working with federal, state and
local governments, as well as industry partners to meet the needs
of the communities we serve across the country during the
pandemic,” said Richard Ashworth, Walgreens president. “We’re
continuing to do everything we can, both with our own resources and
also by partnering with others, to serve as an access point within
the community for COVID-19 testing. Opening our first drive-thru
testing location last month has allowed us to quickly learn and
develop an efficient and scalable process, and we’re pleased to be
working with Abbott to help accelerate our efforts, and to enable
quick results for those being tested.”
Walgreens will dedicate temporary space at select locations,
outside of the stores, where Walgreens pharmacists will oversee the
self-administration of the COVID-19 test. Soon, patients will be
directed to testing locations via an online assessment tool that
will be available on Walgreens.com and Walgreens mobile app.
Testing will be available at no cost to eligible individuals who
meet criteria established by the Centers for Disease Control and
Prevention (CDC). Patients will need to pre-register in advance in
order to schedule an appointment for testing.
About Walgreens
Walgreens (walgreens.com), one of the nation's largest drugstore
chains, is included in the Retail Pharmacy USA Division of
Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in
retail and wholesale pharmacy. Walgreens is proud to be a
neighborhood health, beauty and retail destination supporting
communities across the country, and was named to FORTUNE*
magazine’s 2019 Companies that Change the World list. Approximately
8 million customers interact with Walgreens in stores and online
each day. As of August 31, 2019, Walgreens operates 9,277
drugstores with a presence in all 50 states, the District of
Columbia, Puerto Rico and the U.S. Virgin Islands, along with its
omnichannel business, Walgreens.com. Walgreens also provides
specialty pharmacy and mail services and offers in-store clinics
and other health care services throughout the United States, most
of which are operated by our health care strategic partners.
*© 2019, Fortune Media IP Limited. Used under license.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200407005255/en/
Phil Caruso media@walgreens.com
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Apr 2023 to Apr 2024